Planta Med 2004; 70(5): 414-420
DOI: 10.1055/s-2004-818968
Original Paper
Pharmacology
© Georg Thieme Verlag KG Stuttgart · New York

Anti-Inflammatory Activity of Two Cucurbitacins Isolated from Cayaponia tayuya Roots

M. Carmen Recio1 , Maite Prieto1 , 2 , Marina Bonucelli1 , Cecilia Orsi1 , Salvador Máñez1 , Rosa M. Giner1 , M. Cerdá-Nicolás3 , José-Luis Ríos1
  • 1Departament de Farmacologia, Facultat de Farmàcia, Universitat de València, Burjassot, Spain
  • 2Instituto Superior de Ciencias Médicas Carlos J. Finlay, Camagüey, Cuba
  • 3Departament de Patologia, Facultat de Medicina, Universitat de València, Valencia, Spain
This work was supported by the Spanish Government (SAF2002-00-723). Maite Prieto (fellowship from Universitat de València).
Further Information

Publication History

Received: October 8, 2003

Accepted: January 25, 2004

Publication Date:
04 May 2004 (online)

Zoom Image

Abstract

Fractionation of an anti-inflammatory extract from Cayaponia tayuya roots yielded two active compounds, identified as 23,24-dihydrocucurbitacin B (1) and cucurbitacin R (2). Both were evaluated for their anti-inflammatory activity on several experimental models of pain and inflammation. In addition, their cytotoxicity and effects on leukotriene B4 (LTB4) formation were evaluated in rat polymorphonuclear leukocytes. Both compounds showed activity in the following models: carrageenan-induced mouse paw oedema (1, 4 mg/kg p. o., 46 % inhibition at 3 h), phospholipase A2-induced mouse paw oedema (2, 3 mg/kg i. p., 61 % inhibition at 60 min), serotonin-induced mouse paw oedema (1 and 2, 0.5 mg/kg s. c., 73 % and 79 % inhibition, respectively), 12-O-tetradecanoylphorbol 13-acetate (TPA)-induced acute ear oedema (2, 36 % inhibition at 4 mg/kg p. o., and 87 % inhibition at 0.1 mg/ear topically). The compounds were also active against the inflammation induced by repeated application of TPA on mouse ears, affecting both the oedema itself (1 and 2 at 0.1 mg/ear, 44 % and 56 % inhibition, respectively) as well as cell infiltration (68 % and 69 %, respectively). The activity of both compounds against oedema induced by serotonin was not modified by the glucocorticoid receptor antagonist mifepristone; however, the protein synthesis inhibitor cycloheximide abolished the anti-inflammatory response in both cases. Neither compound modified the production of LTB4 in rat polymorphonuclear leukocytes, nor did they exhibit analgesic properties at the dose assayed.